Previous studies have indicated that T2DM was fundamentally a chronic low-grade inflammatory disease, as evidenced by remarkable elevation of inflammatory factors such as serum interleukin-6 (IL-6), tumor necrosis factor (TNF), and C-reactive protein (CRP) (3–6). The gene discussed is CRP; the disease is type 2 diabetes mellitus.